{"blog": [], "keywords": [{"value": "Editorials", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Tests (Medical)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Clinical Trials", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "5", "is_major": "Y"}, {"value": "Research", "name": "subject", "rank": "6", "is_major": "Y"}], "web_url": "http://www.nytimes.com/2016/04/12/opinion/making-the-most-of-clinical-trial-data.html", "document_type": "article", "byline": {"person": [], "original": "By THE EDITORIAL BOARD", "organization": "THE EDITORIAL BOARD"}, "type_of_material": "Editorial", "multimedia": [{"url": "images/2016/04/12/opinion/12tue3web/12tue3web-thumbWide.jpg", "legacy": {"wide": "images/2016/04/12/opinion/12tue3web/12tue3web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/04/12/opinion/12tue3web/12tue3web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/12/opinion/12tue3web/12tue3web-articleLarge.jpg", "xlargeheight": "398", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 398}, {"url": "images/2016/04/12/opinion/12tue3web/12tue3web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/12/opinion/12tue3web/12tue3web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Opinion", "word_count": "390", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Data from past clinical trials can be incredibly valuable but researchers rarely take advantage.", "pub_date": "2016-04-12T00:00:00Z", "news_desk": "Editorial", "headline": {"kicker": "Editorial", "print_headline": "Making the Most of Clinical Trial Data", "main": "Making the Most of Clinical Trial Data", "content_kicker": "Editorial"}, "print_page": "22", "snippet": "Data from past clinical trials can be incredibly valuable but researchers rarely take advantage.", "_id": "570ca1e538f0d863e460bcb7", "slideshow_credits": null, "abstract": "Editorial supports case made by editors of The Journal of The American Medical Assn for broad sharing of clinical trial data among medical researchers, which many academic institutions and smaller drug companies do not do; calls for more funding from government agencies like National Institutes of Health and nonprofits to help fund cost of maintaining centralized databases and data analysis itself. "}